Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA controversially approves potent opioid up to ten times stronger than fentanyl

November 6, 2018
Sales and Marketing Dsuvia, FDA, US, fentanyl, opioid crisis, opioids, pharma

Despite voices of criticism, the FDA has opted to approve AcelRX’s Dsuvia (sufentanil), an opioid medication said to be five …

News
5204602349_c87b204860_z

Aurobindo pharma initiate recall of blood pressure drug Ibesartan

November 6, 2018
Manufacturing and Production, Research and Development Aurobindo Pharma, FDA, heart drug, ibesartan, recall

Indian pharma firm Aurobindo Pharma Ltd has initiated a voluntary recall of 22 batches of blood pressure drug Ibesartan, due …

News
display-dummy-757451_1920

76% of patients no longer experience PTSD a year after MDMA-assisted psychotherapy

November 6, 2018
Manufacturing and Production, Research and Development MDMA, PTSD, mental health, psychotherapy, research

Promising phase II results suggest that MDMA-assisted psychotherapy may be an “innovative, efficacious treatment for posttraumatic stress disorder,” according to …

News
6813384933_1fb31d73fb_z

HIV drug reduces viral load by 99% within 4 weeks

November 6, 2018
Manufacturing and Production, Research and Development

HIV-drug Gammora may eliminate 99% of the HIV virus within four weeks of treatment, according to the results of a …

News
shutterstock_159488225

GSK’s anti-seizure drug shows promise in early depression study

November 2, 2018
Medical Communications, Research and Development GSK, GlaxoSmithKline, Potiga, depression, pharma

Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, ITH Pharma, J&J, JJ, NICE, Sanofi, Trump, top 10

Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …

News
alk_logo_32_nodith

Committee advises against FDA approval of Alkermes’ novel depression drug

November 2, 2018
Medical Communications, Sales and Marketing Alkermes, FDA, depression, pharma

Alkermes has been knocked back with the disappointing, though not entirely unexpected, news that the FDA-appointed Psychopharmacologic Drugs Advisory Committee …

News

Novo Nordisk cuts 1300 jobs in the midst of Trump’s pricing pressures and depreciation of US dollar

November 2, 2018
Medical Communications Jobs, Novo Nordisk, Trump, pressure, pricing, revenue

Danish multinational Novo Nordisk has said that they will have cut 1,300 employees by the end of 2018. The decision …

News
gwpharma

GW Pharma’s Epidiolex becomes first cannabis-based medicine to be made available in United States

November 2, 2018
Medical Communications Epidiolex, GW Pharma, Medical marijuana, cannabidiol, cannabis

GW Pharma’s Epidiolex has become the first plant-derived, cannabis-based medicine to be made available on prescription in all 50 US …

News

Galectin-3: The protein paving new treatment avenues

November 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma

Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …

Feature

Sanofi teams up with Denali in $1.125bn neurological and inflammatory development deal

November 1, 2018
Research and Development, Sales and Marketing Denali Therapeutics, Sanofi, pharma

Sanofi has sealed the deal with Denali Therapeutics to leverage the latter’s small molecule candidates in the development of new …

News
medicinal_cannabis_uk_review

Medical Marijuana to be legalised in Thailand and Malaysia as drug becomes available on prescription in UK

November 1, 2018
Business Services, Medical Communications Medical marijuana, UK, cannabis, malaysia, thailand

Thailand’s public health ministry is working to make medical marijuana legal by next month. The shift is expected to come …

News
gehrynovartis

Novartis cuts 20% of research projects

November 1, 2018
Business Services, Research and Development Business, Novartis, gene therapy, infectious diseases, research

Swiss multinational Novartis has cut a fifth of its research projects, as it abandons 90 of its 430 drug development …

News
merckincweb2

MSD’s Keytruda/chemo combo scores first-line FDA approval in NSC lung cancer

November 1, 2018
Sales and Marketing Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

MSD’s blockbuster anti-PD-1 immunotherapy has secured another FDA approval, it has emerged, in combination with carboplatin and either paclitaxel or …

News

Parents should ignore anti-vaccine “social media fake news”, according to England’s medical chief

November 1, 2018
Medical Communications England, MMR, Vaccine, anti-vaccine, fake news

England’s Chief Medical Officer Dame Sally Davies has said that the MMR vaccine is “a safe vaccination” as she encouraged …

News
shutterstock_92671375

Metropolitan Police charge ITH Pharma over IV feed-linked baby deaths

October 31, 2018
Research and Development ITH Pharma, Metropolitan Police, NHS, pharma

An investigation into the deaths and illnesses of several babies at a number of UK hospitals has prompted London’s Metropolitan …

News
astrazeneca_plaque

AstraZeneca flogs two drug licenses in $922 million deal

October 31, 2018
Research and Development, Sales and Marketing AstraZeneca, pharma

AstraZeneca has signed a deal with Grünenthal worth up to $922 million in which the latter will acquire the regional …

News
eye2

Common diabetes drug can protect against age-related macular degeneration, research shows

October 31, 2018
Research and Development age-related macular degeneration, diabetes, eye, metformin, pharma

A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower …

News

J&J’s Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk

October 31, 2018
Research and Development, Sales and Marketing FDA, J&J, JJ, invokana, pharma

The FDA has given the go-ahead for Johnson & Johnson’s drug Invokana (canagliflozin) for use in the risk reduction of …

News

NICE turns down Sanofi’s Caprelsa for rare thyroid cancer

October 31, 2018
Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma

NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026